Dr. Anna Hill will provide support for the laboratory’s quality and compliance.  Having overseen dozens of accreditation inspections (including the nation’s first accreditation of a laboratory under A2LA’s Platinum Choice Accreditation Program), Dr. Hill brings unmatched expertise in quality management.

She will oversee the generation of the lab’s standard operating procedures and offer guidance to ensure that all build-out efforts are conducted in compliance with the requirements of CLIA and other accreditation agencies.

Dr. Preeti Purwaha implements quality and compliance protocols for new laboratories/accounts, monitors, reviews, and approves quality assurance and quality control metrics, performs customized SOP development for CLIA/CAP/COLA compliance, performs on-site laboratory audits to ensure quality and compliance, provides training and support for Quality programs for new personnel and leads and participates in CLIA, CAP, and COLA inspections. As a Laboratory Director and Supervisor, Dr. Purwaha manages operations and ensures Quality compliance at these labs. Being an excellent team player, Dr. Purwaha collaborates effectively with data analysis, laboratory personnel, and operations teams to carry out Quality related tasks and maintain a high-quality laboratory environment.

Dr. Purwaha is a Certified NRCC (HHS approved board) Toxicological Chemist (CLIA qualified High Complexity Clinical Laboratory Director), and Senior Quality Scientist with extensive technical and managerial expertise in both research and clinical laboratories. Dr. Purwaha has a Ph.D. in Pharmaceutical Sciences from North Dakota State University, Fargo, ND. Dr. Purwaha brings with her about 10 years of technical expertise in LC/MS based method development and validation methodologies for the analysis of small molecules, drugs, drug metabolites, and toxicological agents, and several years of experience in laboratory Quality Management. Dr. Purwaha has published several research articles in top-rated peer-reviewed journals and has been an invited speaker at several national conferences.

Dr. Sharp is board-certified in Clinical Chemistry by the National Registry of Certified Chemists (NRCC) and is a Diplomate of the American Board for Clinical Chemistry (ABCC). She received her Ph.D. in Pharmacology and Toxicology from the University of Louisville in 2018 and completed a Clinical Chemistry Fellowship at the same institution in July 2020.

Dr. Sharp will provide support for the laboratory’s quality and compliance. She will oversee proficiency testing for the laboratory and ensure that competency and training requirements are met for all testing personnel. Her focus is on improving quality in the lab and quality-related workflows for the company. She also serves as Laboratory Director for several laboratories.

A Clinical Laboratory Director and Laboratory Science expert in Chemistry and Toxicology Diagnostics. Dr. Nahire leads the majority of Chemistry and Toxicology projects and serves several CLIA positions in different Reference Labs and POLs across the United States. Toxicology method development, validation, troubleshooting, and preparing labs for CLIA/COLA/CAP inspection are his primary areas of expertise.

Dr. Nahire is a certified Toxicological Chemist by HHS approved National Registry of Clinical Chemists (NRCC). He is a Certified Specialist in Chemistry by the American Society of Clinical Pathologists (ASCP). He has a Masters in Pharmaceutical Analysis and Doctorate in Pharmaceutical Sciences. He has published several peer-reviewed research articles, presented his research in several conferences, and filed patents.